宫腔镜下切除癌前及恶性子宫内膜息肉:是否为子宫切除术的安全替代方案?
该回顾性病历回顾纳入1998至2016年间1766例宫腔镜息肉切除术患者,其中43例(2.4%)诊断为癌前或恶性息肉,34例(79.0%)行子宫切除并纳入研究。子宫切除标本中24例(88.9%)存在残留癌前病变或子宫内膜癌,多数(55.6%)为多灶性。作者认为宫腔镜评估和息肉切除不足以根除癌前及恶性子宫内膜病变,该替代方案应保留用于经过良好选择的病例。
要点
- 43例(2.4%)诊断为癌前或恶性息肉,其中子宫内膜癌21例、复杂不典型增生22例。
- 34例行子宫切除者中,24例(88.9%)子宫标本存在残留癌前病变或癌,55.6%为多灶性。
- 作者认为宫腔镜息肉切除不足以根除癌前及恶性子宫内膜病变,应仅用于严格选择的病例。
核心结论
- 作者认为宫腔镜评估宫腔及息肉切除不足以根除癌前及恶性子宫内膜病变,该替代方案应保留用于经过良好选择的病例,如保留生育功能及有手术危险因素、息肉切除后将接受进一步药物治疗的患者。
研究设计与样本
- 回顾性病历回顾(加拿大工作组分类II-2),大学医院,1998至2016年间1766例行宫腔镜息肉切除术的女性。
- 纳入息肉病理为复杂不典型增生或子宫内膜样癌并接受子宫切除的患者,排除非子宫内膜样病理。
- 共43例(2.4%)诊断为癌前或恶性息肉(子宫内膜癌21例、复杂不典型增生22例),其中34例(79.0%)行子宫切除并纳入研究组。
主要发现
- 研究组中位年龄62岁(范围35-83岁),多数女性(79.4%)表现为绝经后出血或月经过多。
- 13例(38.2%)切除超过1枚息肉,息肉中位大小2 cm(范围1-4)。
- 27例女性宫腔镜检查除切除息肉外未见其他可见子宫内膜异常。
- 34例行子宫切除的女性中,24例(88.9%)子宫标本存在残留复杂不典型增生或子宫内膜癌,其中多数(55.6%)为多灶性病变。
临床怎么用
- 作者认为宫腔镜评估宫腔及息肉切除不足以根除癌前及恶性子宫内膜病变,该替代方案应保留用于经过良好选择的病例,如保留生育功能及有手术危险因素、息肉切除后将接受进一步药物治疗的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: The standard treatment of endometrial cancer (EC) and complex atypical hyperplasia (CAH) is hysterectomy with or without adnexectomy. In the last decade several centers have attempted to perform hysteroscopic resection of malignant and premalignant polyps as an alternative to hysterectomy. In the present study we evaluated the safety of this procedure in regard to residual uterine pathology. DESIGN: Retrospective chart review (Canadian Task Force classification II-2). SETTING: University hospital. PATIENTS: Women (n = 1766) who underwent hysteroscopic polypectomy during the years 1998 to 2016. INTERVENTIONS: Patients with CAH and endometrioid type EC in the removed polyps who underwent hysterectomy were included in the study. Patients with nonendometrioid pathology were excluded. The operative and pathologic reports of the hysteroscopy and hysterectomy procedures were revised. MEASUREMENTS AND MAIN RESULTS: Forty-three women (2.4%) were diagnosed with premalignant and malignant polyps: 21 with EC and 22 with CAH. Thirty-four women (79.0%) underwent hysterectomy and were included in the study group. The median age was 62 years (range, 35-83). Most women (79.4%) presented with postmenopausal bleeding or menorrhagia. In 13 patients (38.2%) more than 1 polyp was removed. The median size of the polyps was 2 cm (range, 1-4). In 27 women there were no other visible endometrial findings during the hysteroscopy except for the removed polyp. However, in 24 women (88.9%) residual CAH or EC was present in the hysterectomy specimen, mostly (55.6%) as multifocal lesions. CONCLUSION: Our results indicate that hysteroscopic evaluation of the uterine cavity and polyp resection are not enough for the eradication of premalignant and malignant endometrial lesions. This alternative should be reserved for well-selected cases such as for fertility preservation and for patient with surgical risk factors that after the hysteroscopic polypectomy will receive further medical treatment.
引用
- Elyashiv O, Sagiv R, Kerner R, et al. Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy? J Minim Invasive Gynecol. 2017. PMID: 28802955. doi:10.1016/j.jmig.2017.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。